Paraganglioma — Trials

Paraganglioma — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06233903	18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System	withdrawn	Phase 2	0	Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)INDUSTRY	1	Jan 21, 2025	clinicaltrials
NCT04276597	Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.(PUTNET)	withdrawn	Phase 2	0	Excel Diagnostics and Nuclear Oncology Center